Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of Neoadjuvant Chemotherapy and Preoperative Irradiation on Early Complications in Direct-to-Implant Breast Reconstruction

  • Ji Won Hwang (Department of Plastic and Reconstructive Surgery, Ewha Womans University Mokdong Hospital) ;
  • Su Min Kim (Department of Plastic and Reconstructive Surgery, Ewha Womans University Mokdong Hospital) ;
  • Jin-Woo Park (Department of Plastic and Reconstructive Surgery, Ewha Womans University Mokdong Hospital) ;
  • Kyong-Je Woo (Department of Plastic and Reconstructive Surgery, Ewha Womans University Mokdong Hospital)
  • Received : 2024.05.31
  • Accepted : 2024.06.23
  • Published : 2024.09.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background Impact of previous radiation therapy and neoadjuvant chemotherapy (NACT) on early complications in direct-to-implant (DTI) breast reconstruction has not been elucidated. This study investigated whether DTI reconstruction is viable in patients with NACT or a history of preoperative chest wall irradiation. Methods Medical records of breast cancer patients who underwent nipple-sparing or skin-sparing mastectomy with DTI breast reconstruction from March 2018 to February 2021, with at least 1 year of follow-up in a single tertiary center, were reviewed. Demographic data, intraoperative details, and postoperative complications, including full-thickness necrosis, infection, and removal, were reviewed. Risk factors suggested by previous literature, including NACT and preoperative chest wall irradiation histories, were reviewed by multivariate analysis. Results A total of 206 breast cancer patients were included, of which, 9 were bilateral, 8 patients (3.9%) had a history of prior chest wall irradiation, and 17 (8.6%) received NACT. From 215 cases, 11 cases (5.1%) required surgical intervention for full-thickness necrosis, while intravenous antibiotics or hospitalization was needed in 11 cases (5.1%), with 14 cases of failure (6.5%) reported. Using multivariable analysis, preoperative irradiation was found to significantly increase the risk of full-thickness skin necrosis (OR = 12.14, p = 0.034), and reconstruction failure (OR = 13.14, p = 0.005). NACT was not a significant risk factor in any of the above complications. Conclusion DTI breast reconstruction is a viable option for patients who have received NACT, although reconstructive options should be carefully explored for patients with a history of breast irradiation.

Keywords

Acknowledgement

The authors would like to express their gratitude to HyeAh Lee, a statistician at Ewha Womans University Mokdong Hospital, for conducting the statistical analysis for this study.

References

  1. Farhangkhoee H, Matros E, Disa J. Trends and concepts in postmastectomy breast reconstruction. J Surg Oncol 2016;113(08):891-894
  2. Hunsicker LM, Ashikari AY, Berry C, Koch RM, Salzberg CA. Shortterm complications associated with acellular dermal matrixassisted direct-to-implant breast reconstruction. Ann Plast Surg 2017;78(01):35-40
  3. Colwell AS, Damjanovic B, Zahedi B, Medford-Davis L, Hertl C, AustenWGJr. Retrospective reviewof 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 2011;128(06):1170-1178
  4. Kaufmann M, Hortobagyi GN, Goldhirsch A, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006;24(12):1940-1949
  5. Mitchem J, Herrmann D, Margenthaler JA, Aft RL. Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy. Am J Surg 2008;196(04):519-522
  6. Riba J, de Romani SE, Masia J. Neoadjuvant chemotherapy for breast cancer treatment and the evidence-based interactionwith immediate autologous and implant-based breast reconstruction. Clin Plast Surg 2018;45(01):25-31
  7. Lee MC, Rogers K, Griffith K, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J 2009;15(01):34-40
  8. Momoh AO, Ahmed R, Kelley BP, et al. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Ann Surg Oncol 2014;21(01):118-124
  9. Aliu O, Zhong L, Chetta MD, et al. Comparing health care resource use between implant and autologous reconstruction of the irradiated breast: a national claims-based assessment. Plast Reconstr Surg 2017;139(06):1224e-1231e
  10. Riggio E, Toffoli E, Tartaglione C, Marano G, Biganzoli E. Local safety of immediate reconstruction during primary treatment of breast cancer. Direct-to-implant versus expander-based surgery. J Plast Reconstr Aesthet Surg 2019;72(02):232-242
  11. Ataseven B, von Minckwitz G. The impact of neoadjuvant treatment on surgical options and outcomes. Ann Surg Oncol 2016;23(10):3093-3099
  12. Song J, Zhang X, Liu Q, et al. Impact of neoadjuvant chemotherapy on immediate breast reconstruction: a meta-analysis. PLoS ONE 2014;9(05):e98225
  13. Lorentzen T, Heidemann LN, Moller S, Bille C. Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol 2022;48(01):44-52
  14. Scardina L, Di Leone A, Biondi E, et al. Prepectoral vs. submuscular immediate breast reconstruction in patients undergoing mastectomy after neoadjuvant chemotherapy: our early experience. J Pers Med 2022;12(09):1533
  15. Varghese J, Gohari SS, RizkiH, et al. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction. Breast 2021;55:55-62
  16. Frey JD, Choi M, Karp NS. The effect of neoadjuvant chemotherapy compared to adjuvant chemotherapy in healing after nipplesparing mastectomy. Plast Reconstr Surg 2017;139(01):10e-19e
  17. Allue Cabanuz M, Arribas Del Amo MD, Gil Romea I, Val-Carreres Rivera MP, Sousa Dominguez R, Guemes Sanchez AT. Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: a safe option? Cir Esp (Engl Ed) 2019;97(10):575-581
  18. Kracoff S, Allweis TM, Ben-Baruch N, Benkler M, Fadi S, Egozi D. Neo-adjuvant chemotherapy does not affect the immediate postoperative complication rate after breast reconstruction. Breast J 2019;25(03):528-530
  19. Kronowitz SJ, Robb GL. Radiation therapy and breast reconstruction: a critical review of the literature. Plast Reconstr Surg 2009;124(02):395-408
  20. McCarthy CM, Mehrara BJ, Riedel E, et al. Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 2008;121(06):1886-1892
  21. Spear SL, Boehmler JH,BogueDP,Mafi AA.Options inreconstructing the irradiated breast. Plast Reconstr Surg 2008;122(02):379-388
  22. Hirsch EM, Seth AK, Dumanian GA, et al. Outcomes of tissue expander/implant breast reconstruction in the setting of prereconstruction radiation. Plast Reconstr Surg 2012;129(02):354-361
  23. Prantl L, Moellhoff N, von Fritschen U, et al. Effect of radiation therapy on microsurgical deep inferior epigastric perforator flap breast reconstructions: a matched cohort analysis of 4577 cases. Ann Plast Surg 2021;86(06):627-631
  24. Ascherman JA, Hanasono MM, Newman MI, Hughes DB. Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 2006;117(02):359-365
  25. Li Y, Xu G, Yu N, Huang J, Long X. Prepectoral versus subpectoral implant-based breast reconstruction: a meta-analysis. Ann Plast Surg 2020;85(04):437-447